Neonatal TPN Starter Bags Recalled for Sterility Assurance Failure
Central Admixture Pharmacy Services is recalling 84 bags of neonatal TPN starter bags due to lack of sterility assurance and missing validation data for decontamination cycles.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall involving a critical pharmaceutical product—sterile IV solution for neonates. While no illnesses or injuries have been reported, the hazard is significant: lack of sterility assurance in intravenous products for vulnerable neonatal patients represents a serious risk of harm if contamination occurred during manufacturing or decontamination.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling 84 bags of Neonatal TPN Starter Bag (Amino Acids 3%/Dextrose 10% with Calcium, 250 mL) due to a lack of assurance of sterility and missing validation data for decontamination cycles.
The affected product is Lot 36-251696 with expiration date 7/15/2023 (NDC 72196-0405-1). The product was distributed nationwide in the United States.
Neonates receiving TPN from affected bags may have been exposed to potential contamination. Healthcare providers and pharmacies should identify patients who may have received this product and consult with appropriate authorities regarding monitoring and management of affected patients.
The recalled product
- Product
- Neonatal TPN Starter Bag, Amino Acids (trophamine) 3%/Dextrose 10% with CALCIUM, total volume = 250mL, IV Bag, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0405-1
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — Injectable / IV Solution
- Hazard
- sterility-failure
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 36-251696
- Exp. 7/15/2023.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27